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Introduction

• Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has been reported to cause a myriad of manifestations and complications.
• There are several documented cases of idiopathic thrombocytopenia purpura
(ITP) as well as autoimmune hemolytic anemia (AIHA).
3
• Xu et al described the mechanism of thrombocytopenia related to COVID-19 as
multifactorial including lung injury resulting in increased platelet consumption,
direct infection of bone marrow stromal cells, and cytokine storm resulting in
destruction of bone marrow progenitor cells.
• There are documented cases of lymphopenia secondary to proposed
4
lymphocyte apoptosis during inflammatory storms.
•T
 wo cases of severe neutropenia in neonates have been reported by Venturini
5
et al in association with mild COVID-19.

Clinical Course

• Placed on empiric antibiotics secondary to severe neutropenia
• Nasopharyngeal swab detected SARS-CoV-2
• Developed hypoxemia requiring escalation of care to our pediatric intensive care
unit and high flow oxygen therapy was initiated
• Corticosteroids and antiviral (remdesivir) initiated
hospital day 3
laboratory findings
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Case Description

• 17-year-old female with a history of trisomy 21, aortic insufficiency, celiac disease,
and obesity
• Transferred with complaints of dehydration, fever, diarrhea, and a recent, known
household member positive for SARS-CoV-2
• 5-day history of fever, lethargy, mucopurulent nasal secretions, reduced oral
intake, and decreased urine output prior to admission
admission vital signs

Temp
99.4 °F

Pulse
102

Resp
20

admission laboratory findings

BP
98/82

SpO2
97%

BMI
34.73

3.2

132.0

37.1

Absolute neutrophil count: 798

Absolute neutrophil count: 1,568

• Hospital day 5 transferred to general
pediatrics floor and weaned off
oxygen support
• Discharged home the following day
once tolerating room air
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• Previous cases of bone marrow suppression related to COVID-19 include:
33-year-old female patient who underwent extensive evaluation for
myelodysplasias including bone marrow biopsy and ultimately received
granulocyte colony-stimulating factor (G-CSF) for severe neutropenia 11 days
6
following acute SARS-CoV-2 infection.
5-month-old diagnosed with multisystem inflammatory syndrome in children
(MIS-C) in the setting of 36-hour history of persistent fever, perineal cellulitis,
and lip ulceration with a negative SARS-CoV-2 PCR but positive IgG and IgM
was noted to have severe neutropenia treated with G-CSF.
23-day-old and a 39-day-old neonate with mild COVID-19 were noted to have
1
severe neutropenia that resolved without intervention.
• Bone marrow suppression by well-known viruses could explain the
hematological manifestations of SARS-CoV-2.
• Individuals with trisomy 21 are at increased risk of developing hematologic
disturbances.
12
5-10% of infants with trisomy 21 develop transient myeloproliferative disease.
Mutations in GATA 1 are well recognized in trisomy 21 to cause
13
megakaryocyte and erythroid abnormalities but not myeloid.
• Leukopenia, thrombocytopenia, and severe neutropenia remain novel findings.
•B
 one marrow biopsy may not be indicated in patients with SARS-CoV-2
infection and hematological abnormalities given the transient suppression of
blood cell lines.

admission imaging

13.9
0.9

one month later outpatient
laboratory findings

Conclusions
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